AINewsnow

AI-Designed Drug Shows Signs of Lowering Biological Age in Early Clinical Study

This story is from 2026-09-07. It is preserved in the archive; the latest stories are on the live feed.

Insider Brief An artificial intelligence-designed drug for a deadly lung disease produced protein changes associated with lower biological age, offering early evidence that AI-discovered medicines could be evaluated for effects beyond the diseases they were created to treat. Researchers reported in…

Read the full story at AI Insider ↗

Timeline · 1 report

  1. 2026-09-07 18:58 · AI Insider
    AI-Designed Drug Shows Signs of Lowering Biological Age in Early Clinical Study

More stories

  1. Introducing Kimi K3 on Amazon Bedrock — AWS Machine Learning Blog
  2. Introducing Amazon SageMaker HyperPod Inference Gateway — AWS Machine Learning Blog
  3. Anthropic, OpenAI, SpaceXAI, Google sued over call to ‘pace’ AI development — Politico Technology
  4. Gemini Hacked Three Companies in First Known Breakout by Google’s AI — Wall Street Journal Technology
  5. Alibaba ships Qwen3.8-Omni-Flash to watch, listen and call tools — r/LocalLLM
  6. NVIDIA CEO Jensen Huang rejects ‘AI will end the world’ claim, yet cautions ‘we should go as fast as we can but...’ — Mint AI
  7. Meet the Data Agent in ChatGPT Work — OpenAI YouTube
  8. AI hallucination of Chinese nuclear components almost led to US military attack — Ars Technica AI

Get the daily brief of stories like this at 6:30 every morning →